Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)

Sponsor
Sean Devitt (Other)
Overall Status
Recruiting
CT.gov ID
NCT04725916
Collaborator
(none)
100
1
2
21.7
4.6

Study Details

Study Description

Brief Summary

This is a prospective randomized, controlled, unblinded, interventional feasibility study to evaluate if showering with post operative drains in place leads to an increase in complications. The patients included in the study will be those undergoing breast reductions and panniculectomies at Geisinger Medical Center. The patients will be randomized post operatively into one of two groups: 1) patients instructed to shower with drains in place, and 2) patients instructed not to shower while they have drains in place.

Condition or Disease Intervention/Treatment Phase
  • Other: Showering
  • Other: Restriction of Showering
N/A

Detailed Description

This is a prospective randomized, controlled, unblinded interventional feasibility trial evaluating the post-operative outcomes of surgical patients undergoing breast reduction or panniculectomy procedures. Approximately 100 eligible subjects will undergo their surgical procedure according to standard clinical guidelines. Unless clinically contraindicated, study surgeons will maintain consistent use of 10 Flat drains for all study participants to prevent any sampling bias.

Immediately after surgery is completed, the study investigator will randomize the subject into one of the 2 study arms. The randomization scheme will control for procedure type.

The study will not be blinded. The randomization assignment will be communicated to the care team and documented in the subject's electronic medical record to ensure that appropriate post-operative instruction is provided to the subject. Subjects will be notified of their study arm assignment at the time they receive their post-operative discharge instruction.

Subjects in both arms will complete a questionnaire related to quality of life post-operatively, as well as daily bathing specifics.

The following statistical methods will be used for the aims:

Aim 1: Collect and describe information related to outcome measures in addition to study data including number eligible, response rates, adherence/compliance rates.

Descriptive statistics will be provided for all study enrollment data, compliance information as well as data collected throughout the study including outcome measures and responses from the satisfaction survey.

Aim 2: To compare the surgical site complication rate of post-operative patients with drains who shower versus those who do not shower.

Complication rates between the two study arms will be compared using chi-squared tests, although these comparisons will not be conclusive since the study isn't powered to assess equivalence.

Aim 3: To compare patient post-operative satisfaction for those who shower versus those who do not shower.

Patient post-operative satisfaction between the two study arms will be compared using chi-squared tests, although these comparisons will not be conclusive since the study isn't powered to assess differences.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
Actual Study Start Date :
Feb 23, 2022
Anticipated Primary Completion Date :
Aug 15, 2023
Anticipated Study Completion Date :
Dec 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Study Arm 1

Subjects assigned to Arm 1 will be instructed to shower daily beginning on post-operative Day 2 and maintain this daily schedule until the subject's 3-month standard of care clinic follow-up visit. They will receive specific instructions on caring for the incision site and drains until they are removed.

Other: Showering
Patients will be instructed to shower after surgery with drains in place

Active Comparator: Study Arm 2

Subjects assigned to Arm 2 will be instructed not to shower post-operatively until their surgical drains are removed. They will receive specific instructions on bathing and caring for the incision sites and drains.

Other: Restriction of Showering
Patients will be restricted from showering post operatively if they have drains in place

Outcome Measures

Primary Outcome Measures

  1. Drain site cellulitis [12 weeks]

    At each post operative appointment, the patient's drain sites will be examined for signs of cellulitis including tenderness to palpation and blanching erythema. The decision will be based on clinical exam by the physicians assistant, confirmed with the attending physician, and photos will be taken for documentation.

  2. Incisional cellulitis [12 weeks]

    At each post operative appointment, the patient's incision will be examined for signs of cellulitis including tenderness to palpation and blanching erythema. The decision will be based on clinical exam by the physicians assistant, confirmed with the attending physician, and photos will be taken for documentation.

  3. Seroma formation [12 weeks]

    At each post operative visit, the patient will be examined to rule out the presence of wound seroma. Any seroma requiring needle aspiration with removal of fluid will be documented as a positive seroma.

  4. Abscess formation [12 weeks]

    The patient will be examined at each post operative visit. Any collection of bacteria (abscess) that requires bedside drainage will be recorded as an abscess.

  5. Wound dehiscence [12 weeks]

    Development of wound dehiscence during follow-up period

  6. Patient Satisfaction [12 weeks]

    Measurement of patient satisfaction of post-operative ability to shower based on administration of a satisfaction survey

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients having one of the following procedures at Geisinger Medical Center in which drains are placed

  • Breast reduction

  • Lower panniculectomy

  • Fleur-de-lis panniculectomy

  • ≥18 years of age

  • Able and willing to provide consent

Exclusion Criteria:
  • Patients on antibiotics at the time of surgery

  • Patients sent home on antibiotics after surgery

  • Patients who work in healthcare with direct patient contact

  • Patients having a panniculectomy to be eligible for a kidney transplant

  • Patients having a ventral hernia repair at the time of the panniculectomy

  • Patients admitted to the hospital for >1 night

Contacts and Locations

Locations

Site City State Country Postal Code
1 Geisinger Health Danville Pennsylvania United States 17822

Sponsors and Collaborators

  • Sean Devitt

Investigators

  • Principal Investigator: Sean Devitt, MD, Geisinger Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sean Devitt, Sponsor-Investigator, Geisinger Clinic
ClinicalTrials.gov Identifier:
NCT04725916
Other Study ID Numbers:
  • 2020-0970
First Posted:
Jan 27, 2021
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sean Devitt, Sponsor-Investigator, Geisinger Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022